COVID-19-associated thrombotic angiopathy improved after plasma exchange
- PMID: 34853683
- PMCID: PMC8614092
- DOI: 10.1002/ccr3.4991
COVID-19-associated thrombotic angiopathy improved after plasma exchange
Abstract
Utilization of therapeutic plasma exchange in select patients with COVID-19 microangiopathy may provide useful treatment by modulation of inflammatory cytokines and coagulation cascade to maintain homeostasis.
Keywords: COVID; TTP; angiopathy; coagulation; inflammation; plasma exchange; thrombosis.
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
None of the authors declare any conflict of interest.
Figures
References
-
- Sweeney JM, Barouqa M, Krause GJ, Gonzalez‐Lugo JD, Rahman S, Gil MR. Evidence for secondary thrombotic microangiopathy in COVID‐19. medRxiv. 2020;1–2. 10.1101/2020.10.20.20215608 - DOI
Publication types
LinkOut - more resources
Full Text Sources